Rossari Biotech

Rossari Biotech

671.30
-1.25
(-0.19%)
hide
Key Fundamentals
Add Ratio
Market Cap
3,723.70 Cr
EPS
24.66
PE Ratio
27.19
Dividend Yield
0.07 %
Industry
Chemicals
52 Week High
897.95
52 Week Low
569.00
PB Ratio
2.97
Debt to Equity
0.15
Analyst Rating and Forecast
- By Refinitiv from4 analysts
BUY
Analysts have suggested that investors can buy this stock
Buy
Buy+100.00 %
+100.00 %
Hold
Hold0.0 %
0.0 %
Sell
Sell0.0 %
0.0 %
Forecast For
Actual

Company News

View All News
Caret
positive
Rossari Biotech expects strong growth from its performance chemicals and textile specialties segments. The company anticipates growth driven by demand recovery, benefits from backward integration, and scaling up exports. These factors are expected to contribute to double-digit margin expansion.
positive
Rossari Biotech Limited announced its quarterly results for the quarter ended September 30, 2025, showing consolidated revenue from operations of Rs 5,861.07 million and profit after tax of Rs 368.76 million. The company's Board approved granting 35,000 stock options under its Employee Stock Option Plan 2019 at an exercise price of Rs 661 per option. Additionally, the Board approved allotment of 14,400 equity shares at Rs 425 per share to employees exercising their stock options, increasing the total issued share capital to Rs 11,07,62,732 consisting of 55,381,366 equity shares. The company also approved an additional investment of up to USD 8 million in its wholly owned subsidiary Rossari International Limited Company in Saudi Arabia for manufacturing and trading activities. The investment will be made in tranches by March 31, 2027.
positive
Rossari Biotech has commissioned an expansion of its Dahej facility, adding 20,000 MTPA capacity and bringing its total capacity to 1,52,500 MTPA. Separately, Unitop Chemicals has commissioned 15,000 MTPA ethoxylation capacity at Dahej, raising its total capacity to 51,000 MTPA.
View more
Competitors
LTP
Market Cap (₹ Cr.)
P/E Ratio
Revenue (₹ Cr.)
YoY Revenue Growth %
Net Profit (₹ Cr.)
YoY Profit Growth %
RSI
1,542.70
#1 1,54,997.80
71.22
13,387.50
6.91
#1 2,096
18.69
60.29
3,169.40
94,559.50
65.65
14,825.80
12.13
1,251
71.41
73.26
3,718.40
41,133.30
65.55
4,853.20
10.61
546
70.37
53.30
5,108.80
25,898.30
73.78
2,393.10
12.83
289
#1 128.91
67.76
1,770.20
24,215.20
39.78
8,365.80
7.84
697
-44.54
41.31
4,526.80
19,893.20
49.52
#1 15,339.40
10.81
479
-37.72
45.20
1,695.10
17,670.80
41.29
2,292.50
18.24
405
23.75
46.87
5,952.00
17,158.70
#1 31.00
5,692.40
#1 18.99
499
30.75
40.83
4,520.70
13,800.10
33.47
2,366.70
7.83
411
3.35
39.41
374.80
13,653.50
57.30
7,285.40
14.16
331
-68.61
43.06

Automatic Screeners on ScanX

Growth Rate
Revenue Growth
13.40 %
Net Income Growth
4.36 %
Cash Flow Change
217.71 %
ROE
-7.78 %
ROCE
-13.05 %
EBITDA Margin (Avg.)
-7.72 %

Quarterly Financial Results

Quarterly Financials
Jun 2019
Sept 2019
Dec 2019
Mar 2020
Jun 2020
Sept 2020
Dec 2020
Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Revenue
129
151
163
162
112
176
211
220
234
387
434
442
436
426
390
410
413
485
467
473
491
499
514
582
545
588
Expenses
106
122
133
136
86
142
176
182
194
339
381
387
377
369
335
352
353
420
400
409
425
432
448
510
476
514
EBITDA
23
29
30
26
26
34
35
38
40
48
53
56
59
58
55
58
60
65
67
64
66
67
66
71
70
74
Operating Profit %
17 %
19 %
18 %
15 %
22 %
18 %
16 %
17 %
16 %
12 %
11 %
12 %
13 %
13 %
14 %
13 %
14 %
13 %
14 %
13 %
13 %
13 %
13 %
12 %
12 %
12 %
Depreciation
4
4
4
5
4
6
6
7
6
10
16
17
15
16
16
16
14
15
15
16
15
15
18
18
18
18
Interest
1
1
1
1
1
1
0
1
1
2
5
5
5
8
5
4
6
5
4
3
4
4
5
6
6
6
Profit Before Tax
19
24
25
20
21
28
28
30
33
36
33
34
39
34
35
37
40
45
48
46
47
48
42
48
46
50
Tax
5
6
6
5
5
7
7
8
9
10
10
10
10
10
9
8
10
12
13
11
12
13
11
13
13
13
Net Profit
14
18
18
15
16
21
22
22
25
26
23
24
29
24
26
29
29
33
34
34
35
35
32
34
34
37
EPS in ₹
2.93
3.66
3.77
3.11
3.19
4.07
4.16
4.32
4.52
4.77
4.09
4.37
5.21
4.34
4.66
5.25
5.30
5.97
6.23
6.18
6.32
6.39
5.73
6.22
6.07
6.66

Balance Sheet

Balance Sheet
2019
2020
2021
2022
2023
2024
2025
Total Assets
250
472
561
1,257
1,368
1,572
1,896
Fixed Assets
74
94
181
607
585
578
598
Current Assets
160
326
355
609
720
844
1,042
Capital Work in Progress
3
22
0
1
16
47
140
Investments
0
18
0
36
51
63
84
Other Assets
173
338
380
612
715
885
1,074
Total Liabilities
250
472
561
1,257
1,368
1,572
1,896
Current Liabilities
122
149
150
295
349
425
537
Non Current Liabilities
4
36
2
157
104
100
174
Total Equity
124
287
409
805
915
1,048
1,185
Reserve & Surplus
119
277
398
794
904
1,037
1,174
Share Capital
4
10
10
11
11
11
11

Cash Flow

Cash Flow
2019
2020
2021
2022
2023
2024
2025
Net Cash Flow
5
24
-14
22
32
-44
19
Investing Activities
-37
-190
-37
-299
-181
-104
-183
Operating Activities
71
57
48
29
152
43
137
Financing Activities
-29
157
-25
292
61
16
65

Share Holding

% Holding
Mar 2021
Apr 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Promoter
72.69 %
68.70 %
68.70 %
68.56 %
68.56 %
68.56 %
68.56 %
68.46 %
68.44 %
68.43 %
68.43 %
68.35 %
68.33 %
68.32 %
68.32 %
68.27 %
68.19 %
68.18 %
68.17 %
68.17 %
FIIs
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
4.03 %
3.83 %
3.74 %
3.74 %
3.98 %
3.48 %
2.69 %
DIIs
11.26 %
12.53 %
12.32 %
12.62 %
12.52 %
12.13 %
12.86 %
14.02 %
14.08 %
15.09 %
17.71 %
17.68 %
18.02 %
17.75 %
16.87 %
17.34 %
17.47 %
17.59 %
17.84 %
18.18 %
Government
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail
3.69 %
4.20 %
4.75 %
5.00 %
5.17 %
6.05 %
6.44 %
6.53 %
6.97 %
7.15 %
7.14 %
7.53 %
8.76 %
9.14 %
9.96 %
9.57 %
9.51 %
9.20 %
9.44 %
9.47 %
Others
12.36 %
14.57 %
14.23 %
13.82 %
13.75 %
13.27 %
12.15 %
10.99 %
10.51 %
9.33 %
6.72 %
6.45 %
4.89 %
0.76 %
1.02 %
1.09 %
1.09 %
1.05 %
1.07 %
1.48 %
No of Share Holders
0
40,105
40,671
49,324
65,831
76,494
92,099
98,565
95,664
97,081
95,371
95,200
1,00,423
98,859
1,00,475
97,188
95,735
92,852
91,791
91,387

Dividend History

Annual Cash Flows 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Dividend Per Share (₹) 0.00 0.00 0.00 0.00 0.5 0.5 0.5 0.5 0.5 0.5
Dividend Yield (%) 0.00 0.00 0.00 0.00 0.05 0.05 0.08 0.07 0.08 0.07

Corporate Action

Record Date Corporate Action Information Announcement Day LTP at Annoucement LTP at Record Day
11 Sept 2021 DIVIDEND Dividend
₹ 0.50 /share
08 Sept 2021 1,257.20 1,394.10
08 Jul 2022 DIVIDEND Dividend
₹ 0.50 /share
07 Jul 2022 886.05 858.45
24 May 2023 DIVIDEND Dividend
₹ 0.50 /share
24 May 2023 688.40 710.60
16 Aug 2024 DIVIDEND Dividend
₹ 0.50 /share
16 Aug 2024 770.80 909.55
23 Aug 2024 ANNUAL GENERAL MEETING Annual General Meeting
NA
23 Aug 2024 798.60 907.00
19 Oct 2024 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 Oct 2024 854.05 875.80
11 Nov 2024 EXTRAORDINARY GENERAL MEETING Extraordinary General Meeting
NA
11 Nov 2024 875.80 817.80
21 Jan 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
21 Jan 2025 825.75 819.85
25 Apr 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
25 Apr 2025 687.55 704.60
20 Jun 2025 DIVIDEND Dividend
₹ 0.50 /share
20 Jun 2025 704.60 662.40
30 Jun 2025 ANNUAL GENERAL MEETING Annual General Meeting
NA
30 Jun 2025 667.15 681.85
19 Jul 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
19 Jul 2025 700.60 743.30
15 Oct 2025 QUARTERLY RESULT ANNOUNCEMENT Quarterly Result Announcement
NA
15 Oct 2025 628.40 647.05

Announcements

Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome13 hours ago
Announcement under Regulation 30 (LODR)-Newspaper Publication15 hours ago
Announcement under Regulation 30 (LODR)-Press Release / Media Release1 day ago
Announcement under Regulation 30 (LODR)-Investor Presentation1 day ago
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015 2 days ago
Intimation Of Grant Of Options Under Rossari Employee Stock Option Plan - 2019.2 days ago
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPS2 days ago
Unaudited Financial Results (Standalone & Consolidated) For The Quarter And Half Year Ended September 30 2025.2 days ago
Board Meeting Outcome for Outcome Of Board Meeting Held On October 15 2025.2 days ago
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation8 days ago
Intimation Of Change In Communication Details Of Registrar And Share Transfer Agent8 days ago
Board Meeting Intimation for Board Meeting Intimation For Unaudited Financial Results (Standalone And Consolidated) For The Quarter And Half Year Ended September 30 2025.10 days ago
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Oct 03, 2025
Closure of Trading WindowSep 26, 2025
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Sep 26, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationSep 16, 2025
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Sep 02, 2025
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Sep 02, 2025
Disclosures under Reg. 29(2) of SEBI (SAST) Regulations 2011Sep 02, 2025
Disclosures under Reg. 29(1) & 29(2) of SEBI (SAST) Regulations 2011Sep 02, 2025
Disclosures under Reg. 10(6) of SEBI (SAST) Regulations 2011Sep 02, 2025
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 29, 2025
Disclosures under Reg. 10(5) in respect of acquisition under Reg. 10(1)(a) of SEBI (SAST) Regulations 2011Aug 21, 2025
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015.Aug 20, 2025
Update On Investor Call.Aug 20, 2025
Announcement Under Regulation 30 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015Aug 18, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationAug 11, 2025
Announcement under Regulation 30 (LODR)-Earnings Call TranscriptJul 25, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - OutcomeJul 21, 2025
Announcement under Regulation 30 (LODR)-Press Release / Media ReleaseJul 20, 2025
Announcement under Regulation 30 (LODR)-Investor PresentationJul 20, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJul 20, 2025
Announcement under Regulation 30 (LODR)-Allotment of ESOP / ESPSJul 19, 2025
Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025.Jul 19, 2025
Board Meeting Outcome for Outcome Of Board Meeting Held On July 19 2025.Jul 19, 2025
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - IntimationJul 14, 2025
Board Meeting Intimation for Unaudited Financial Results (Standalone And Consolidated) For The Quarter Ended June 30 2025Jul 11, 2025
Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018Jul 04, 2025
Shareholder Meeting / Postal Ballot-Scrutinizers ReportJul 01, 2025
Shareholder Meeting / Postal Ballot-Outcome of AGMJul 01, 2025
Closure of Trading WindowJun 26, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationJun 07, 2025
Announcement Under Regulation 30 -Letters To Non-Email ShareholdersJun 06, 2025
Business Responsibility and Sustainability Reporting (BRSR)Jun 06, 2025
Notice Of 16Th Annual General Meeting Of The CompanyJun 06, 2025
Reg. 34 (1) Annual Report.Jun 06, 2025
Announcement under Regulation 30 (LODR)-Newspaper PublicationMay 30, 2025
Intimation Of 16Th Annual General Meeting Of The Company.May 28, 2025
Intimation Of Record Date.May 28, 2025
Compliances-Reg.24(A)-Annual Secretarial ComplianceMay 28, 2025

Technical Indicators

RSI(14)
Neutral
59.51
ATR(14)
Volatile
23.75
STOCH(9,6)
Neutral
62.86
STOCH RSI(14)
Overbought
82.30
MACD(12,26)
Bullish
3.25
ADX(14)
Weak Trend
18.45
UO(9)
Bearish
56.07
ROC(12)
Uptrend And Accelerating
9.56
WillR(14)
Overbought
-19.66